Harvard researchers’ immune-silent stem cell technology licensed to Sana Biotechnology
Developed through Harvard's Blavatnik Biomedical Accelerator, innovations could lead to novel cell therapies to treat diseaseCredit: Mary Todd Bergman, Harvard Stem Cell Institute. Cambridge, Mass....